• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

信使核糖核酸转录本分析提高了鸟氨酸转氨甲酰酶缺乏症分子基因检测的成功率。

Analysis of mRNA transcripts improves the success rate of molecular genetic testing in OTC deficiency.

作者信息

Engel Katharina, Nuoffer Jean-Marc, Mühlhausen Chris, Klaus Vera, Largiadèr Carlo R, Tsiakas Konstantinos, Santer René, Wermuth Bendicht, Häberle Johannes

机构信息

Universitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Strasse 33, 48149 Münster, Germany.

出版信息

Mol Genet Metab. 2008 Jul;94(3):292-7. doi: 10.1016/j.ymgme.2008.03.009. Epub 2008 Apr 25.

DOI:10.1016/j.ymgme.2008.03.009
PMID:18440262
Abstract

BACKGROUND

Ornithine transcarbamylase (OTC) deficiency is the most common inborn error of urea metabolism that can lead to hyperammonemic crises and orotic aciduria. To date, a total of 341 causative mutations within the OTC gene have been described. However, in about 20% of the patients with enzymatically confirmed OTC deficiency no mutation can be detected when sequencing of genomic DNA analyzing exons and adjacent intronic segments of the OTC gene is performed.

METHODS

Standard genomic DNA analysis of the OTC gene in five consecutive patients from five families revealed no mutation. Hence, liver tissue was obtained by needle sampling or open biopsy and RNA extracted from liver was analyzed.

RESULTS

Complex rearrangements of the OTC transcript (three insertions and two deletions) were found in all five patients.

CONCLUSION

In patients with a strong suspicion of OTC deficiency despite normal results of sequencing exonic regions of the OTC gene, characterization of liver OTC mRNA is highly effective in resolving the genotype. Liver tissue sampling by needle aspiration allows for both enzymatic analysis and RNA based diagnostics of OTC deficiency.

摘要

背景

鸟氨酸转氨甲酰酶(OTC)缺乏症是尿素代谢中最常见的先天性错误,可导致高氨血症危象和乳清酸尿症。迄今为止,已描述了OTC基因内总共341个致病突变。然而,在约20%经酶学证实为OTC缺乏症的患者中,对OTC基因的外显子和相邻内含子片段进行基因组DNA测序时,未检测到突变。

方法

对来自五个家庭的五名连续患者进行OTC基因的标准基因组DNA分析,未发现突变。因此,通过针吸活检或开放活检获取肝组织,并对从肝脏提取的RNA进行分析。

结果

在所有五名患者中均发现了OTC转录本的复杂重排(三个插入和两个缺失)。

结论

对于尽管OTC基因外显子区域测序结果正常但高度怀疑为OTC缺乏症的患者,肝脏OTC mRNA的特征分析在解析基因型方面非常有效。通过针吸进行肝组织采样可同时进行OTC缺乏症的酶学分析和基于RNA的诊断。

相似文献

1
Analysis of mRNA transcripts improves the success rate of molecular genetic testing in OTC deficiency.信使核糖核酸转录本分析提高了鸟氨酸转氨甲酰酶缺乏症分子基因检测的成功率。
Mol Genet Metab. 2008 Jul;94(3):292-7. doi: 10.1016/j.ymgme.2008.03.009. Epub 2008 Apr 25.
2
Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.对五名日本鸟氨酸转氨甲酰酶(OTC)缺乏症患者的OTC基因进行突变分析,发现了两个已知突变和三个新突变,其中包括一个内含子深处的突变。
Kobe J Med Sci. 2007;53(5):229-40.
3
High-frequency detection of deletions and variable rearrangements at the ornithine transcarbamylase (OTC) locus by oligonucleotide array CGH.通过寡核苷酸阵列比较基因组杂交技术对鸟氨酸转氨甲酰酶(OTC)基因座的缺失和可变重排进行高频检测。
Mol Genet Metab. 2009 Mar;96(3):97-105. doi: 10.1016/j.ymgme.2008.11.167. Epub 2009 Jan 12.
4
Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.鸟氨酸转氨甲酰酶缺乏症患者的临床结局及OTC基因突变谱
J Hum Genet. 2015 Sep;60(9):501-7. doi: 10.1038/jhg.2015.54.
5
Complete deletion of ornithine transcarbamylase gene confirmed by CGH array of X chromosome.通过X染色体比较基因组杂交阵列证实鸟氨酸转氨甲酰酶基因完全缺失。
J Inherit Metab Dis. 2007 Oct;30(5):813. doi: 10.1007/s10545-007-0578-y. Epub 2007 Jun 14.
6
Lymphocyte mRNA analysis of the ornithine transcarbamylase gene in Italian OTCD male patients and manifesting carriers: identification of novel mutations.意大利鸟氨酸转氨甲酰酶缺乏症男性患者及有症状携带者中鸟氨酸转氨甲酰酶基因的淋巴细胞mRNA分析:新突变的鉴定
Hum Mutat. 2000 Apr;15(4):380-1. doi: 10.1002/(SICI)1098-1004(200004)15:4<380::AID-HUMU12>3.0.CO;2-Q.
7
OTC gene in ornithine transcarbamylase deficiency: clinical course and mutational spectrum in seven Korean patients.鸟氨酸转氨甲酰酶缺乏症中的OTC基因:7例韩国患者的临床病程及突变谱
Pediatr Neurol. 2014 Sep;51(3):354-359.e1. doi: 10.1016/j.pediatrneurol.2014.03.029. Epub 2014 May 29.
8
Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.在鸟氨酸转氨甲酰酶(OTC)缺乏症患者中鉴定出该基因的七个新错义突变、两个剪接位点突变、两个微缺失和一个多态性氨基酸替代。
Hum Mutat. 2002 Feb;19(2):185-6. doi: 10.1002/humu.9011.
9
[Molecular diagnosis of OTC gene mutation in a Chinese family with ornithine transcarbamylase deficiency].[一个患有鸟氨酸转氨甲酰酶缺乏症的中国家庭中OTC基因突变的分子诊断]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Apr;30(2):195-8. doi: 10.3760/cma.j.issn.1003-9406.2013.04.016.
10
[Analysis of ornithine transcarbamylase gene mutations in three boys affected with late-onset ornithine transcarbamylase deficiency].[三名迟发性鸟氨酸转氨甲酰酶缺乏症男孩的鸟氨酸转氨甲酰酶基因突变分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014 Oct;31(5):565-9. doi: 10.3760/cma.j.issn.1003-9406.2014.01.005.

引用本文的文献

1
Characterization and treatment monitoring of ureagenesis disorders using stable isotopes.使用稳定同位素对尿素生成障碍进行表征和治疗监测。
NPJ Metab Health Dis. 2025;3(1):19. doi: 10.1038/s44324-025-00051-8. Epub 2025 May 6.
2
Exploring RNA therapeutics for urea cycle disorders.探索用于尿素循环障碍的 RNA 疗法。
J Inherit Metab Dis. 2024 Nov;47(6):1269-1277. doi: 10.1002/jimd.12807. Epub 2024 Oct 24.
3
Palm kernel meal regulates the expression of genes involved in the amino acid metabolism in the liver of Tibetan sheep.
棕榈仁粕调节藏羊肝脏中氨基酸代谢相关基因的表达。
BMC Vet Res. 2024 Jul 23;20(1):333. doi: 10.1186/s12917-024-04193-7.
4
Induced pluripotent stem cell technology as diagnostic tool in patients with suspected ornithine transcarbamylase deficiency lacking genetic confirmation.诱导多能干细胞技术作为缺乏基因确诊的疑似鸟氨酸转氨甲酰酶缺乏症患者的诊断工具。
Mol Genet Metab Rep. 2023 Sep 6;37:101007. doi: 10.1016/j.ymgmr.2023.101007. eCollection 2023 Dec.
5
Three-Country Snapshot of Ornithine Transcarbamylase Deficiency.鸟氨酸转氨甲酰酶缺乏症三国概况
Life (Basel). 2022 Oct 27;12(11):1721. doi: 10.3390/life12111721.
6
Pathogenic variants of ornithine transcarbamylase deficiency: Nation-wide study in Japan and literature review.鸟氨酸转氨甲酰酶缺乏症的致病变体:日本全国性研究及文献综述
Front Genet. 2022 Oct 11;13:952467. doi: 10.3389/fgene.2022.952467. eCollection 2022.
7
Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.致病性假外显子分析揭示了驱动隐蔽剪接的新机制。
Front Genet. 2022 Jan 24;12:806946. doi: 10.3389/fgene.2021.806946. eCollection 2021.
8
A spotter's guide to SNPtic exons: The common splice variants underlying some SNP-phenotype correlations.SNPtic 外显子观察指南:一些 SNP 表型相关性背后的常见剪接变体。
Mol Genet Genomic Med. 2022 Jan;10(1):e1840. doi: 10.1002/mgg3.1840. Epub 2021 Oct 28.
9
A deep intronic variant is a common cause of OTC deficiency in individuals with previously negative genetic testing.深度内含子变异是既往基因检测呈阴性的个体中鸟氨酸转氨甲酰酶缺乏症的常见病因。
Mol Genet Metab Rep. 2021 Jan 8;26:100706. doi: 10.1016/j.ymgmr.2020.100706. eCollection 2021 Mar.
10
[Consensus on diagnosis and treatment of ornithine trans-carbamylase deficiency].鸟氨酸转氨甲酰酶缺乏症诊断与治疗共识
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Oct 25;49(5):539-547. doi: 10.3785/j.issn.1008-9292.2020.04.11.